In-Depth Analysis of the Drug Eluting Balloons Catheters Market Share: Growth Opportunities, Key Trends, and Forecast 2025-2034

What combination of drivers is leading to accelerated growth in the drug eluting balloons catheters Market Share?
The increasing occurrence of peripheral and cardiovascular diseases is anticipated to boost the expansion of the drug-eluting balloon catheter Market Share. Cardiovascular diseases (CVDs) encapsulate a variety of conditions affecting the heart and circulatory system, while peripheral artery disease (PAD) specifically denotes a state where reduced blood flow is caused by narrow arteries, primarily to the arms or legs. Drug-eluting balloon catheters, a treatment option for coronary artery disease (CAD), employ a semi-compliant angioplasty balloon covered with an anti-proliferative agent that can exert an anti-restenotic impact when it enters the vessel. For example, as per the Centers for Disease Control and Prevention in May 2024, heart disease was responsible for 702,880 deaths in the US in 2022, constituting 1 in every 5 deaths. Every year in the US, around 805,000 individuals suffer a heart attack - approximately 605,000 being first-time occurrences and 200,000 in those who have previously experienced it. Thus, the rising prevalence of peripheral and cardiovascular diseases is propelling the drug-eluting balloon catheter Market Share. The augmenting demand for minimally invasive procedures is anticipated to spur the drug-eluting balloon catheter Market Share growth. They are surgical methods that involve small incisions; this consequently lessens wound healing time, pain, and infection risk. Drug-eluting balloons are deployed in these minimal procedures to transport medication directly to the treatment site, modulating restenosis prevention and enhancing the efficacy of vascular interventions. For example, as per Intuitive Surgical Inc. in January 2023, the number of surgery performed via Vinci surgical systems rose by about 18% from 1,594,000 in 2021 to 1,875,000 in 2022. Furthermore, as per the American Society of Plastic Surgeons in 2022, the tally of cosmetic minimally invasive procedures conducted in the US swelled to 23,672,269 that year. Therefore, the escalating demand for minimally invasive surgeries is fueling the drug-eluting balloon catheter Market Share's growth.

Get Your Drug Eluting Balloons Catheters Market Share Report Here:
https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-Market Share-report

What is the projected compound annual growth rate (CAGR) of the drug eluting balloons catheters Market Share from 2025 to 2034, and what factors influence it?
The size of the drug-eluting balloons catheters Market Share has seen a swift expansion in recent times. The Market Share's growth is projected to surge from $1.43 billion in 2024 to $1.66 billion in 2025, maintaining a compound annual growth rate (CAGR) of 16.0%. This escalation in the historical span is credited to factors such as a rise in respiratory ailments, benefits compared to traditional inhalers, patient inclination towards dpis, government-driven initiatives focusing on respiratory wellness, strategic alliances and partnerships, advancements in medicine formulations, and an increasing elderly population.

The Market Share size for drug-eluting balloon catheters is anticipated to witness swift expansion in the subsequent years, reaching a worth of $2.61 billion in 2029 with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to the growth during this projected period include rising cases of respiratory illnesses, growing elderly population, heightened awareness and education, Market Share growth in developing economies, personalized drug formulations, adherence and support from regulatory bodies, along with innovative packaging and design ideas. Upcoming trends during the forecast period comprise smart inhalers incorporating connectivity, a move towards breath-actuated inhalers, concentration on the necessities of pediatric and geriatric patients, delivery of biologics, as well as inhaler designs that are ecologically friendly.

Get Your Free Sample Now - Explore Exclusive Market Share Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

What new trends are reshaping the drug eluting balloons catheters Market Share and its opportunities?
Leading firms in the drug-eluting balloon catheter industry are making efforts to develop the latest generation products embedded with advanced technology in order to maintain a competitive position in the Market Share. For example, Boston Scientific Corporation, an engineering company specializing in biomedical/biotechnology with a global presence in manufacturing medical devices, heralded in March 2024 that it had successfully received approval for the AGENT Drug-Coated Balloon (DCB) from the U.S. Food and Drug Administration (FDA). Positioned as the inaugural drug-coated coronary balloon accessible in the U.S, the AGENT DCB is designed for treating in-stent restenosis (ISR), a condition characterized by blockage of a stented vessel due to plaque or scar tissue. The innovative product features a coating of paclitaxel that delivers a therapeutic dose to the vessel wall, minimizing the recurrence of ISR without the need for additional stents or radiation. Clinical trials indicate a reduction in the risk of heart attack at the target site by 49%, and the occurrence of adverse events was also reported to be low.

What are the major segments of the drug eluting balloons catheters Market Share and their role in driving growth?
The drug eluting balloons catheters Market Share covered in this report is segmented -

1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
2) By Drug: Paclitaxel, Sirolimus, Other Drugs
3) By Raw Material: Nylon, Polyurethane, Other Raw Materials
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

Subsegments:
1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters, Plain Balloon Catheters
2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters, Angioplasty Balloon Catheters
3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters

Unlock Exclusive Market Share Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13429

Which regions are key players in the growth of the drug eluting balloons catheters Market Share?
North America was the largest region in the drug eluting balloons catheters Market Share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters Market Share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the drug eluting balloons catheters Market Share?
Major companies operating in the drug eluting balloons catheters Market Share report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

Customize Your Report - Get Tailored Market Share Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

What Is Covered In The Drug Eluting Balloons Catheters Global Market Share Report?

• Market Share Size Forecast: Examine the drug eluting balloons catheters Market Share size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the drug eluting balloons catheters Market Share for a structured understanding.
• Key Players Overview: Analyze major players in the drug eluting balloons catheters Market Share, including their Market Share value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the drug eluting balloons catheters Market Share.
• Segment Contributions: Evaluate how different segments drive overall growth in the drug eluting balloons catheters Market Share.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the drug eluting balloons catheters Market Share.
• Industry Challenges: Identify potential risks and obstacles affecting the drug eluting balloons catheters Market Share.
• Competitive Landscape: Review strategic developments in the drug eluting balloons catheters Market Share, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.